These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 34243960)

  • 1. Role of vortioxetine in the treatment of neuropathic pain.
    Alcántara Montero A; Pacheco de Vasconcelos SR
    Rev Esp Anestesiol Reanim (Engl Ed); 2021 Jul; ():. PubMed ID: 34243960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of vortioxetine in the treatment of neuropathic pain.
    Alcántara Montero A; Pacheco de Vasconcelos SR
    Rev Esp Anestesiol Reanim (Engl Ed); 2022 Dec; 69(10):640-648. PubMed ID: 36241510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vortioxetine: A new alternative for the treatment of major depressive disorder.
    Salagre E; Grande I; Solé B; Sanchez-Moreno J; Vieta E
    Rev Psiquiatr Salud Ment (Engl Ed); 2018; 11(1):48-59. PubMed ID: 28800937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multimodal antidepressant vortioxetine causes analgesia in a mouse model of chronic neuropathic pain.
    Zuena AR; Maftei D; Alemà GS; Dal Moro F; Lattanzi R; Casolini P; Nicoletti F
    Mol Pain; 2018; 14():1744806918808987. PubMed ID: 30289053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Dual Noradrenergic Mechanism for the Relief of Neuropathic Allodynia by the Antidepressant Drugs Duloxetine and Amitriptyline.
    Kremer M; Yalcin I; Goumon Y; Wurtz X; Nexon L; Daniel D; Megat S; Ceredig RA; Ernst C; Turecki G; Chavant V; Théroux JF; Lacaud A; Joganah LE; Lelievre V; Massotte D; Lutz PE; Gilsbach R; Salvat E; Barrot M
    J Neurosci; 2018 Nov; 38(46):9934-9954. PubMed ID: 30249798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vortioxetine for depression in adults.
    Koesters M; Ostuzzi G; Guaiana G; Breilmann J; Barbui C
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD011520. PubMed ID: 28677828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Desvenlafaxine and neuropathic pain: additional clinical benefits of a second generation serotonin-noradrenaline reuptake inhibitor].
    Alcantara-Montero A
    Rev Neurol; 2017 Mar; 64(5):219-226. PubMed ID: 28229443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vortioxetine: a New Treatment for Major Depressive Disorder.
    Connolly KR; Thase ME
    Expert Opin Pharmacother; 2016; 17(3):421-31. PubMed ID: 26679430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Update in the pharmacological treatment of neuropathic pain].
    Alcántara Montero A; Ibor Vidal PJ; Alonso Verdugo A; Trillo Calvo E
    Semergen; 2019; 45(8):535-545. PubMed ID: 31337589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of cognitive dysfunction in major depressive disorder--a review of the preclinical evidence for efficacy of selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors and the multimodal-acting antidepressant vortioxetine.
    Pehrson AL; Leiser SC; Gulinello M; Dale E; Li Y; Waller JA; Sanchez C
    Eur J Pharmacol; 2015 Apr; 753():19-31. PubMed ID: 25107284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vortioxetine as a new frontier in the treatment of chronic neuropathic pain: a review and update.
    Adamo D; Calabria E; Coppola N; Pecoraro G; Mignogna MD
    Ther Adv Psychopharmacol; 2021; 11():20451253211034320. PubMed ID: 34497709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vortioxetine for major depressive disorder: An indirect comparison with duloxetine, escitalopram, levomilnacipran, sertraline, venlafaxine, and vilazodone, using number needed to treat, number needed to harm, and likelihood to be helped or harmed.
    Citrome L
    J Affect Disord; 2016 May; 196():225-33. PubMed ID: 26938965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New generation antidepressants for depression in children and adolescents: a network meta-analysis.
    Hetrick SE; McKenzie JE; Bailey AP; Sharma V; Moller CI; Badcock PB; Cox GR; Merry SN; Meader N
    Cochrane Database Syst Rev; 2021 May; 5(5):CD013674. PubMed ID: 34029378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonin and Norepinephrine Reuptake Inhibitors.
    Shelton RC
    Handb Exp Pharmacol; 2019; 250():145-180. PubMed ID: 30838456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duloxetine versus other anti-depressive agents for depression.
    Cipriani A; Koesters M; Furukawa TA; Nosè M; Purgato M; Omori IM; Trespidi C; Barbui C
    Cochrane Database Syst Rev; 2012 Oct; 10():CD006533. PubMed ID: 23076926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antidepressants in the treatment of neuropathic pain.
    Sindrup SH; Otto M; Finnerup NB; Jensen TS
    Basic Clin Pharmacol Toxicol; 2005 Jun; 96(6):399-409. PubMed ID: 15910402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duloxetine and Amitriptyline Reduce Neuropathic Pain by Inhibiting Primary Sensory Input to Spinal Dorsal Horn Neurons via α1- and α2-Adrenergic Receptors.
    Huang Y; Chen H; Chen SR; Pan HL
    ACS Chem Neurosci; 2023 Apr; 14(7):1261-1277. PubMed ID: 36930958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Impact of vortioxetine on sexual function compared to other antidepressants].
    Sánchez-Sánchez F; Ponce-Buj B; Montejo-González AL; Sipán-Sarrión Y; Gimeno-Marqués A; Merino-Gámez A
    Semergen; 2023 Oct; 49(7):101997. PubMed ID: 37329592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of neuropathic pain with venlafaxine.
    Sumpton JE; Moulin DE
    Ann Pharmacother; 2001 May; 35(5):557-9. PubMed ID: 11346061
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.